Ads
related to: immunosuppressants after kidney transplant- Dosing And Administration
See Dosing For Kidney Transplant
Rejection Prevention.
- Detailed Study Designs
View Study Designs For A Post-
Kidney Transplant Immunosuppressant
- See Study Design Overview
See Study Design Overview & More
For This Immunosuppressive Therapy.
- Selected Pooled Safety
View Important Safety Information
& See Selected Pooled Safety Data.
- Materials And Resources
Download A Dosing Guide Or Watch
A Dosing And Administration Video.
- Patient & Graft Survival
See Clinical Study & Learn How This
Treatment May Impact Your Patients.
- Dosing And Administration
Search results
Results From The WOW.Com Content Network
The drugs, called immunosuppressants, are an essential part of any transplant recipient’s life: They help ensure that the immune system doesn’t attack the donated organ as a “foreign ...
Calcineurin inhibitors and azathioprine have been linked with post-transplant malignancies and skin cancers in organ transplant recipients. Non-melanoma skin cancer (NMSC) after kidney transplantation is common and can result in significant morbidity and mortality. The results of several studies suggest that calcineurin inhibitors have ...
Mycophenolic acid is an immunosuppressant medication used to prevent rejection following organ transplantation and to treat autoimmune conditions such as Crohn's disease and lupus. [12] [13] Specifically it is used following kidney, heart, and liver transplantation. [13] It can be given by mouth or by injection into a vein. [13]
Thymoglobulin and Atgam are currently licensed for use in the treatment of renal allograft rejection; Atgam is additionally licensed for use in the treatment of aplastic anemia. Both drugs are used in off-label applications, especially as immunosuppression induction agents before and/or during kidney transplantation.
Thymoglobulin (manufactured by Sanofi) is an anti-human thymocyte immunoglobulin preparation made of purified polyclonal antibodies derived from rabbits.While these antibodies have a variety of specificities, their main mechanism of immunosuppression is through depletion of T cells.
Muromonab-CD3 (brand name Orthoclone OKT3, marketed by Janssen-Cilag) is an immunosuppressant medication given to reduce acute rejection in people with organ transplants. [1] [2] It is a monoclonal antibody targeted at the CD3 receptor, [3] a membrane protein on the surface of T cells.
Ad
related to: immunosuppressants after kidney transplant